Table 4.
HR | [95% | CI] | p value | |
---|---|---|---|---|
Socio- demographic | ||||
Male gender | 0.98 | 0.64 | 1.50 | 0.929 |
Caucasian race | 1.12 | 0.80 | 1.56 | 0.507 |
IDU | 1.71 | 1.14 | 2.58 | 0.009 |
Age | 1.05 | 1.04 | 1.07 | <0.001 |
Later period | 1.16 | 0.82 | 1.63 | 0.383 |
Residence in NE or W regions | 1.04 | 0.89 | 1.21 | 0.600 |
Baseline status | ||||
CD4 count (100 cell/μl) | 0.84 | 0.75 | 0.93 | <0.001 |
Log HIV-1 VL | 1.47 | 1.15 | 1.88 | 0.002 |
KSHV seropositivity | 1.17 | 0.85 | 1.63 | 0.337 |
Clinical course | ||||
Kaposi Sarcoma | 3.23 | 1.74 | 6.78 | <0.001 |
No CD4count increase | Ref. | |||
Any CD4 count increase | 0.14 | 0.10 | 0.20 | <0.001 |